Mesenchymal stem cell conditioned medium improves hypoxic injury to protect islet graft function

Area of Science:

• * Regenerative Medicine
• * Stem Cell Biology
• * Diabetes Research

Background:

• * Islet transplantation is a promising therapy for type 1 diabetes mellitus (T1DM).
• * Early graft failure due to hypoxia post-transplantation limits treatment success.
• * Mesenchymal stem cells (MSCs) offer protection against hypoxic injury via paracrine signaling.

Purpose of the Study:

• * To evaluate the protective effects of MSC-conditioned medium (MSC-CM) on islet cells under hypoxic conditions.
• * To assess MSC-CM's ability to enhance islet cell tolerance to hypoxia and preserve graft function.
• * To investigate MSC-CM's efficacy in a type 1 diabetes mellitus (T1DM) mouse transplantation model.

Main Methods:

• * MIN6 cells and primary mouse islet cells were exposed to hypoxic conditions (1% oxygen).
• * Cell viability was assessed using AO/PI staining and Annexin/PI flow cytometry.
• * Insulin secretion capacity was measured via glucose-stimulated insulin secretion tests.
• * Islet cells pretreated with MSC-CM were transplanted into NCG T1DM mice to evaluate graft function and survival.

Main Results:

• * Hypoxia significantly reduced MIN6 cell survival and insulin secretion.
• * MSC-CM treatment improved MIN6 cell survival and restored insulin secretion function under hypoxia.
• * Pretreatment with 10% MSC-CM enhanced islet graft survival and function in T1DM mice, evidenced by improved glucose control and insulin staining.

Conclusions:

• * Hypoxia severely impairs islet cell survival and function, hindering T1DM transplantation outcomes.
• * MSC-CM effectively mitigates hypoxia-induced damage and preserves islet graft function in a T1DM mouse model.
• * MSC-CM represents a promising strategy to improve the efficacy of islet transplantation for T1DM.